Kredi Sermaye Değişiklik Tarih
Adma Biologics USD 191.64M 1.2M 2026-09
BioCryst Pharmaceuticals USD 395.61M 209K 2026-09
Eli Lilly USD 46.99B 872M 2026-09
Halozyme Therapeutics USD 2.94B 1.01B 2026-09
Insmed USD 544.86M 1.35M 2026-09
Karyopharm Therapeutics USD 264.49M 13.73M 2026-03
MacroGenics USD 163.16M 94.44M 2026-06
MannKind USD 541.7M 3.43M 2026-09
Merck USD 49.69B 1.39B 2026-09
Minerva Neurosciences USD 0 86.58M 2024-09
Novavax USD 246.3M 200K 2025-12
Novo Nordisk DKK 18.61B 100.56B 2026-06
Pfizer USD 60B 498M 2026-09
Sanofi EUR 16.28B 1.63B 2026-09
Xencor USD 71.93M 5.61M 2026-09